COVID-19
Biosimilars
Cataract Therapeutics
DME
Gene Therapy
Workplace
Ptosis
Optic Relief
Imaging
Geographic Atrophy
AMD
Presbyopia
Ocular Surface Disease
Practice Management
Pediatrics
Surgery
Therapeutics
Optometry
Retina
Cataract
Pharmacy
IOL
Dry Eye
Understanding Antibiotic Resistance
Refractive
Cornea
Glaucoma
OCT
Ocular Allergy
Clinical Diagnosis
Technology

Innovative Drug Delivery Mechanism for Sustained Control of Neovascular AMD : Episode 1

Surgical Considerations and Patient Selection for PDS With Ranibizumab

June 28, 2024

Opinion

Video

Dr. Margaret Chang details the facility requirements for PDS implantation, the specialized training surgeons need, and crucial factors to consider for the surgical implantation of PDS.

Now Viewing

EP: 1.Surgical Considerations and Patient Selection for PDS With Ranibizumab

EP: 2.Overview of the Port Delivery System with Ranibizumab

What facilities are required to implant the device, and what specific training does a surgeon need?
What are the key considerations for the surgical implantation and subsequent refilling of the PDS?
What are the major adverse effects associated with the PDS, and which patients are not suitable candidates for this delivery system?
How does the PDS with ranibizumab fit into the treatment landscape that also includes highly durable agents such as faricimab and high-dose aflibercept?